CHGCF vs PFE: Which Stock is Better?

Side-by-side comparison of Chugai Pharmaceutical Co. Ltd and Pfizer Inc in 2026

Comparison Updated:

CHGCF

Chugai Pharmaceutical Co. Ltd

$60.19

PFE

Pfizer Inc

$27.56

Key Metrics Comparison

MetricCHGCFPFEWinner
Market Cap$99.06B$156.77BPFE
P/E Ratio36.0419.97PFE
EPS (TTM)$1.67$1.38CHGCF
Revenue Growth0.1%-0.0%CHGCF
Gross Margin71.1%75.8%PFE

Analyze CHGCF

Full quant analysis

Analyze PFE

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CHGCF or PFE a better investment?

Comparing CHGCF and PFE: Chugai Pharmaceutical Co. Ltd has a market cap of $99.06B while Pfizer Inc has $156.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CHGCF and PFE?

CHGCF (Chugai Pharmaceutical Co. Ltd) and PFE (Pfizer Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CHGCF or PFE?

Based on P/E ratios, PFE trades at a lower multiple (20.0x vs 36.0x).

Which is growing faster: CHGCF or PFE?

CHGCF has higher revenue growth at 0.1% vs -0.0% for PFE.

Which company is more profitable: CHGCF or PFE?

Pfizer Inc (PFE) has higher gross margins at 75.8% compared to 71.1% for CHGCF.

Which is the larger company: CHGCF or PFE?

Pfizer Inc (PFE) is larger with a market cap of $156.77B compared to $99.06B for CHGCF.

Should I buy CHGCF or PFE in 2026?

Both CHGCF and PFE have investment merit. CHGCF trades at $60.19 while PFE trades at $27.56. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CHGCF and PFE stock?

Key differences: Market Cap ($99.06B vs $156.77B), P/E Ratio (36.0x vs 20.0x), Revenue Growth (0.1% vs -0.0%), Gross Margin (71.1% vs 75.8%).

Popular Stock Comparisons